Alcoholic Liver Disease
A research study providing advanced testing, imaging, and access to new therapies for those with alcohol-related liver damage—working to improve treatment and long-term outcomes.
Alcoholic Liver Disease Study
Focuses on evaluating liver damage and disease progression caused by chronic alcohol use. This study aims to identify new therapies, improve diagnosis, and enhance long-term liver health for affected patients.
1. Comprehensive Liver Function Assessment
Uses blood tests to measure key enzymes (AST, ALT, bilirubin) for indication of liver damage.
Provides a full evaluation of liver health during treatment and recovery.
2. Imaging and Fibrosis Analysis
Utilizes ultrasound, FibroScan, or MRI scans to detect liver scarring (fibrosis), fat accumulation, and cirrhosis.
Tracks changes in liver structure to assess response to therapy.
3. Symptom and Quality-of-Life Monitoring
Assesses symptoms including jaundice, abdominal pain, fatigue, and swelling.
Monitors improvements in day-to-day comfort, activity, and wellbeing.
4. Clinical Drug and Therapy Trials
Offers access to investigational medications and treatments targeting alcoholic liver disease.
Ensures participant safety and treatment effectiveness with expert medical supervision.
Eligible Participants Are
21 to 75 years of age
Diagnosed with alcoholic liver disease or alcohol-related liver damage
History of chronic alcohol consumption
Willing to abstain from alcohol during the study period
Willing to undergo liver imaging and regular blood tests
Additional criteria apply
Eligible Participants May
Receive study-related medical care and treatment at no cost
Receive compensation for study-related time and travel
Gain access to investigational liver therapies and support programs
Contribute to advancing treatment for alcohol-related liver conditions
The Alcoholic Liver Disease Clinical Trial plays a key role in advancing medical understanding and improving treatment for alcohol-related liver conditions. By participating, individuals contribute to research that may reduce serious complications and shape future standards for liver health worldwide.